Advertisement
Home Tags Prescription Drugs

Tag: Prescription Drugs

Early initiation of antiretroviral therapy is associated with improved outcomes in HIV

More Evidence of Benefits for Early Initiation of ART

0
Two studies show benefits in patients with asymptomatic HIV and in African patients
For patients with type 2 diabetes

CVD Risk Similar for Metformin + Insulin or Sulfonylureas

0
Similar risk for second-line therapies for type 2 diabetes in combination with metformin
For women

Metoclopramide Nasal Spray Helps Gastroparesis in Women

0
Nasal spray at 10-mg or 14-mg reduces symptoms for women, but not men, with diabetes
Among hospitalized patients

High Doses of Antibiotic Ups Risk of Over-Anticoagulation

0
High-dose amoxicillin/clavulanate combined with warfarin linked to increased risk of INR ≥4
A new drug

Patiromer Treats Hyperkalemia in Diabetic Kidney Disease

0
All doses of patiromer significantly reduced potassium levels after a month
Patients with inflammatory arthritis want to be informed about multiple current and future treatment options

Arthritis Patients Want Info About Multiple Drug Options

0
Patients with inflammatory arthritis want to be informed about current, future treatment options
Preliminary trial results suggest that an experimental drug may be more efficacious for psoriasis than the current standard treatment. The results were published in the July 9 issue of the New England Journal of Medicine.

Experimental Drug Shows Promise in Treatment of Psoriasis

0
Guselkumab appears more effective than standard treatment, researchers report
Misunderstanding of the term hypertension may impact antihypertensive medication use and adherence

Misunderstanding of Term ‘Hypertension’ May Impact Care

0
Patients may think of hypertension as a psychological condition, related to too much tension
The benefit of extended anticoagulation after pulmonary embolism dissipates after cessation of active therapy

Benefits of Extended Anticoagulation May Not Last

0
New study suggests that oral anticoagulant meds may be needed for the very long term
Rituximab retreatment at clinical relapse is at least as cost-effective as a more intensive regimen in longstanding rheumatoid arthritis

Rituximab Retreatment at Clinical Relapse Cost-Effective in RA

0
At least as cost-effective as more intensive regimen in patients with longstanding RA